Avelos Therapeutics

Avelos Therapeutics

Develops next-generation targeted oncology medicines with high unmet need, to a wider range of possibilities with present and future applications.

HQ location
Seoul, South Korea
Website
avelostx.com
Launch date
Employees
2-10 people
Enterprise value
$50—75m
Company register number
4388702223
https://www.linkedin.com/company/avelostx/
    • Edit
Get premium to view all results
DateInvestorsAmountRound
investor investor investor investor investor investor

€0.0

round
*

$12.5m

Series B
Total Funding000k
SV Investment
SV Investment
UTC Investment
UTC Investment
QUAD Investment Management
QUAD Investment Management
Timefolio Asset Management
Timefolio Asset Management
Mirae Asset Capital
Mirae Asset Capital
Mirae Asset Venture Investment
Mirae Asset Venture Investment
SV Investment
SV Investment
Timefolio Capital
Timefolio Capital
Medytox Venture Investment
Medytox Venture Investment
Shinhan Capital
Shinhan Capital
LSK Investment
LSK Investment
Heungkuk Asset Management
Heungkuk Asset Management
Quad Asset Management
Quad Asset Management
Starset Investment
Starset Investment

Related Content

Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads